Furthermore, the tumor-promoting effects of CCR6/CCL20 within the tumor microenvironment have been reported in many cancer types, such as renal cell carcinoma [43], gastric cancer [44], cervical cancer [45], and lung cancer [46,47]. The gene discussed is CCL20; the disease is neoplasm.